SUMMARY
The stem cells that maintain and repair the postnatal skeleton remain undefined. One model suggests that perisinusoidal mesenchymal stem cells (MSCs) give rise to osteoblasts, chondrocytes, marrow stromal cells, and adipocytes, although the existence of these cells has not been proven through fate-mapping experiments. We demonstrate here that expression of the bone morphogenetic protein (BMP) antagonist gremlin 1 defines a population of osteochondroreticular (OCR) stem cells in the bone marrow. OCR stem cells self-renew and generate osteoblasts, chondrocytes, and reticular marrow stromal cells, but not adipocytes. OCR stem cells are concentrated within the metaphysis of long bones not in the perisinusoidal space and are needed for bone development, bone remodeling, and fracture repair. Grem1 expression also identifies intestinal reticular stem cells (iRSCs) that are cells of origin for the periepithelial intestinal mesenchymal sheath. Grem1 expression identifies distinct connective tissue stem cells in both the bone (OCR stem cells) and the intestine (iRSCs). (legend continued on next page) necessary for postnatal bone growth. The prevailing model for the development, growth, and repair of long bones proposes two phases. First, cartilage cells lay down a matrix that forms a ''scaffold'' for bone formation. Osteoblasts then invade this matrix and lay down the mineralized parts of bone (Kronenberg, 2003) . Although this process-termed ''endochondral ossification''-has been known for decades, it remains unclear whether postnatal bones are grown and repaired by osteoblasts and chondrocytes already committed to their respective lineages, or whether there are specialized multipotent cells that determine postnatal growth and repair. The mesenchymal stem cell (MSC) model suggests that a selfrenewing stem cell exists within the bone marrow that gives rise to mature osteoblasts, chondrocytes, adipocytes, and marrow stromal cells required for skeletal development, homeostasis, and repair. A prime candidate for the endogenous MSC has been the mesenchymal cells that surround the bone marrow sinusoids (Bianco et al., 2013) . Perisinusoidal mesenchymal cells are marked by nestin (Nes)-GFP (Mé ndez-Ferrer et al., 2010) and leptin receptor (Lepr)-cre (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014) in mice and by CD146 in humans (Sacchetti et al., 2007) .
Recently, perisinusoidal mesenchymal cells expressing Lepr were found to include multipotent, colony-forming unit-fibroblasts (CFU-Fs) (Zhou et al., 2014) . Lineage-tracing studies revealed that this perisinusoidal population also contained cells with in vivo osteogenic and adipogenic potential; however, these cells gave rise to osteo-adipogenic lineages exclusively in adult animals (>8 weeks of age) and not during development or bone growth (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014) . Furthermore, Lepr-expressing perisinusoidal cells never contributed to normal developing chondrocytes, the major cell lineage generating the cartilaginous matrix required for endochondral ossification (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014) . Thus, perisinusoidal MSCs do not fulfill all of the characteristics expected of a skeletal MSC. In addition, putative MSC markers such as Nes (Mé ndez-Ferrer et al., 2010) have failed to prove that single MSCs have in vivo postnatal multipotentiality and self-renewal. Together, these data raise the prospect that another complementary postnatal skeletal stem cell may exist.
We developed an inducible Cre transgenic line marking a skeletal stem cell. In doing so, we discovered the osteochondroreticular (OCR) stem cell. We also provide evidence indicating that analogous connective tissue stem cells, intestinal reticular stem cells (iRSCs), exist in the small intestine.
RESULTS

Generating a Specific Marker of Skeletal Stem Cells
To select a specific MSC marker in the bone and intestine, we considered human gene-expression arrays from bone marrow, intestine, and peritumoral mesenchyme (Delorme et al., 2009; Kosinski et al., 2007; Sneddon et al., 2006) . Gremlin 1 (Grem1), identified from these studies, is a secreted antagonist of bone morphogenetic protein (Bmp) -2, -4, and -7 and a VEGFR2 agonist (Hsu et al., 1998; Mitola et al., 2010) . Grem1 is important in normal skeletal and renal development and homeostasis (Canalis et al., 2012; Khokha et al., 2003; Michos et al., 2004) . Furthermore, overexpression of Grem1 interrupts normal intestinal function and has been linked to intestinal cancer (Jaeger et al., 2012) .
We previously found that Grem1 expression identified the most clonogenic fraction of marrow stromal cultures (Quante et al., 2011) . In the present study, we confirmed that expression of Grem1 was increased in undifferentiated mesenchymal cultures compared to endogenous bone marrow mesenchyme (Figures S1A-S1C available online).
To extend these findings in vivo, we generated a tamoxifeninducible BAC transgenic creER T line specific for Grem1 ex- 
CD31
-in enzymatically digested bone and bone marrow cells. CD45 characterizes most hematopoietic cells with the exception of maturing erythroid cells, which are marked by Ter-119. CD31 was used to exclude endothelial cells (Park et al., 2012) (Table S1D green, and Acta2-RFP-expressing cells were red) (Grcevic et al., 2012; Mé ndez-Ferrer et al., 2010 Figure S2C ). Importantly, the proportion of CFU-Fs was diminished within the Grem1 + descendants expressing Acta2-RFP, suggesting that Acta2 expression marks a more differentiated cell less capable of clonogenic growth ( Figure S2D ). Grem1 + cells, however, never gave rise to Nes-GFP-expressing cells, either in adherent culture or in vivo (10 months tracing after adult tamoxifen induction of Grem1-creER T ;R26-LSL-TdTomato;Nes-GFP mice; Figure S2E ).
For the clonal differentiation experiments (Figure 1 ), adult Grem1-creER T ;R26-LSL-ZsGreen;Acta2-RFP and Grem1-creER T ;R26-LSL-TdTomato mice were administered tamoxifen by oral gavage at 6-8 weeks of age. Bones were processed as described (see Experimental Procedures), and the fluorescent Grem1 + cells were sorted by fluorescence-activated cell sorting (FACS) and plated at clonal density < 2,500 cells/10 cm dish. Clones (i.e., isolated clusters of > 50 cells at 10-14 days) were harvested using a cloning cylinder and expanded into individual wells for differentiation. We evaluated 19 clones after in vitro differentiation. Single clones gave rise to osteoblasts (defined by alizarin red [ Figure 1H ] or alkaline phosphatase staining in 84% of clones, [Figures S2F and S2G] ), chondrocytes (100% of clones confirmed by toluidine blue staining), and myofibroblasts on the basis of coexpression of the Acta2-RFP transgene (100%, Figures 1H-1J ). In contrast, the Grem1 + cell-derived clones showed little capacity for adipocytic differentiation (defined by oil red staining, Figure 1K , 0 of 19 single clones 
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+ cells, a subpopulation previously reported to contain all mouse bone marrow CFU-Fs (Park et al., 2012) . It followed that Grem1 + cells were also enriched for CFU-Fs compared to Grem1-negative fractions (Data S1A and S1B). It is worth noting that we used standard adherent cell culture conditions (aMEM with 10% FBS), whereas other studies have used 20% FBS, hypoxic conditions, and a ROCK inhibitor, which enhance the recovery of CFU-Fs (Zhou et al., 2014 Table S1E , and Data S1C and S1E). Grem1 + cells did not differentially express Nes (Figure 2H ) or other genes typical of the perisinusoidal mesenchymal niche (Table S1E) .
To determine the signaling pathways that were activated in the Grem1 + cells, we investigated candidate pathways previously reported to be relevant in MSC differentiation, such as the BMP, TGF-b, FGF/PDGF, and VEGF pathways (Gerber et al., 1999; Ng et al., 2008) . Although all of these pathways were statistically significant (<2.2 3 10 16 by the c2 test), only the genes in the Bmp-activating pathway were consistently increased. Bmp2, Bmp5, Bmp6, the Bmp receptor Acvr1, and the BMP signaling target gene Id2 were all upregulated in Grem1 + versus Grem1-negative mesenchymal cells (Data S1F and Table S1F ). To support the role of BMP signaling in the Grem1 + population, we performed qPCR on 23 clones derived from Grem1 + bone marrow cells. Id2 was expressed in 100% of clones, and Bmp2 was expressed in 91% of clones. Furthermore, using flow cytometry, pSmad1,5, a marker of BMP signaling, was detected in 37.5% of Grem1 + versus 5.8% of Grem1-negative freshly sorted cells (Data S1G, p = 0.004). In contrast, genes identified in the TGF-b, FGF/PDGF, and VEGF pathways were found to be both activators and repressors and so did not generate a coherent signal constituting pathway activation (Data S1F, S1H, and S1I). We also used an unbiased analysis in which all differentially expressed genes in Grem1 + versus Grem1-negative cells (fdr < 0.05) were evaluated against the KEGG and Reactome databases. Pathways with a gamma fdr < 0.05 are included in Table  S1G (KEGG) and Table S1H (Reactome). The top 3 significant KEGG pathways, the ECM-receptor interaction, PI3K-Akt signaling, and focal adhesion pathways, were all activated according to PathwayGuide's statistical criterion. Differentially expressed genes from these pathways are given in Tables S1I-S1K. Many of the genes upregulated in these pathways are involved in differentiation into bone and cartilage and include the following: chondroadherin, cartilage oligomeric matrix protein, fibroblast growth factors, collagens, integrins, and cyclins. Taken together, BMP signaling along with ECM-receptor interaction, PI3K-Akt signaling, and focal adhesion pathways were all significantly activated in the Grem1 + cells and are likely to be important either in determining or as a consequence of the Grem1 + cells' osteochondral lineage potential. The expression profile of Grem1 + cells was enriched for genes implicated in bone and cartilage, rather than adipocytic, differentiation (Data S1J; Tables S1L-S1N). Furthermore,
Grem1
+ cells, and their derivative clones, expressed active inhibitors of adipogenesis (e.g., Nr2f2; Data S1K; Xu et al., 2008) . The exact molecular explanation for the more restricted mesenchymal repertoire of Grem1 + cells, however, remains to be confirmed.
Further qPCR analysis of 23 Grem1 + cell-derived clones confirmed the mesenchymal homogeneity of Grem1 cells and their derivative clones (Data S1L). Interestingly, 100% of the Grem1 + clones expressed both Nes and Grem1, and Grem1 transcripts were also detectable within polyclonal Nes-GFP cultures. Thus, endogenous Grem1 and Nes expression are not as mutually exclusive as their respective transgenes in vivo. Finally, GREM1 is also expressed in human MSCs. We examined three distinct human MSC lines derived from normal bone marrow, normal synovium, or inflamed synovium. All lines expressed GREM1 (Data S1M).
Grem1 Cells Are Endogenous OCR Stem Cells
Grem1-creER T ;R26-LSL-ZsGreen;Acta2-RFP mice were induced with perinatal tamoxifen (postnatal day [P] 1, Figure 3A ). In these mice, all Grem1 + cells and their subsequent progeny were labeled by green fluorescence, and any cells expressing Acta2 were marked by red fluorescence. Twenty-four hours after P1 induction, Grem1 + (green) cells were present within the primitive mesenchyme and the primary spongiosa of the femur. In contrast, the Acta2-expressing (red) stromal cells were localized within the bone marrow ( Figure 3B cence, and osteoblasts are marked by green fluorescence. The 2.3colGFP mouse is a transgenic line in which GFP expression, driven by a short 2.3 kb promoter element from the rat collagen 1a1 gene, has been used to identify committed osteoblasts (Kalajzic et al., 2002) . After 6 weeks, the P1-labeled Grem1 + cells had differentiated into reticular marrow stromal cells (red), chondrocytes (red), and osteoblasts (yellow), all concentrated within the peritrabecular bone area (Figures 3F-3I) . Many of the reticular marrow stromal cells anatomically spanned perivascular and endosteal regions and were CD105
+ by immunostaining (Figure S3A ). As early as 4 weeks (P28) following P1 induction,
Grem1
+ cells give rise to approximately 64% of the bone and 50% of the chondrocytes within the metaphysis and epiphysis, albeit with little contribution to diaphyseal bone ( Figure S3B ).
To prove that the fluorescent cells represented clonal populations, we generated Grem1-creERT;R26-Confetti mice and again induced at P1. Single-color clones of chondrocytes and marrow stromal cells were present by 6 weeks, confirming single-cell multipotentiality ( Figures 3J and 3K ). Our Monte Carlo simulation confirmed that the majority (>90%) of patches of adjacent identically colored cells (''clones'') were likely to be monoclonal in origin (see Experimental Procedures).
Approximately 12 months after adult (6-8 weeks, Figure 3L ) tamoxifen induction of Grem1-creERT;R26-LSL-TdTomato mice (and Grem1-creER T ;R26-LSL-ZsGreen, mice), we found that Grem1 + cells had differentiated into columns of chondrocytes ( Figures 3M and 3N ), articular cartilage ( Figure S3C ), reticular marrow stromal cells ( Figure 3O ), periosteal cells ( Figure 3P ), diaphyseal osteoblasts ( Figure S3D ), and osteocytes ( Figure 3P ). No adipocytes, either in the femurs ( Figure S3E ) or in the vertebral bodies ( Figure S3F ), were derived from adult Grem1 + cells, even at 1 year after tamoxifen induction. Fluorescently labeled Grem1 + cells harvested from the bone marrow after 1 year could still self-renew in vitro. The harvested Grem1 + cells in culture formed large colonies, which were clonally expanded (using cloning cylinders) to prove that they retained clonal in vitro multipotentiality, even 12 months after adult tamoxifen induction ( Figure S3G ). Again, in vitro differentiation was skewed to osteoblast and chondrocyte (Figures S3G-S3J), with little in vitro adipogenesis ( Figure S3H ). These results indicate that expression of Grem1 also identified adult multipotent stem cells. To confirm that Grem1 + cells were functional, postnatal skeletal stem cells, we generated Grem1-creER T ;R26-LSL-ZsGreen;R26-LSL-DTA mice and Grem1-creER T ;R26-LSL-ZsGreen littermate and related controls. In these mice, Cre-mediated excision of a STOP signal leads to the expression of the Diphtheria toxin (DTA) and thus ablation of Grem1-expressing cells. We administered four daily doses of 2 mg subcutaneous tamoxifen starting at P9 and measured total body and left femoral bone volume by microcomputed tomography (CT) at P23 (Quantum FX Micro-CT, Perkin-Elmer; Figures S4A-S4C ). Grem1 cells were incompletely ablated, although reduced, as assessed by the proportion of ZsGreen-expressing cells in the bone marrow ( Figure S4A ). The DTA + mice were significantly smaller than the controls ( Figure S4B ). There was a significant difference in femoral volume between the groups and a trend toward reduced total bone volume in the DTA versus the control mice ( Figure S4C ). 
(legend continued on next page)
We noted that the major site of Grem1-driven recombination at P23, after P9 induction, was within the femoral epiphysis (nearly 60% of the epiphyseal bone was labeled). Therefore, we examined anatomically comparable sections in Grem1 DTA versus control mice and measured the fraction of mineralized bone in the femoral epiphysis. Here too, the trabecular bone fraction was significantly reduced in DTA mice versus control mice ( Figure S4D ). This suggested a functional role of Grem1 + cells in postnatal skeletogenesis. We acknowledge, however, that ablation of extra-skeletal Grem1 + cells may have indirectly contributed, at least in part, to the impaired skeletogenesis.
We measured the expression of Grem1, Nes, Runx2, and Sox9 by whole-mount in situ hybridization during the earliest stages of hindlimb bud development, i.e., embryonic day (E) 9.5, E10.5, E11.5, and E12.5 ( Figure 4A ). Grem1 was expressed at the onset of hindlimb development, E9.5. Nes was not expressed within the hindlimb at these stages. To confirm that Grem1 marked a multipotent mesenchymal stem/progenitor cell during development, we administered tamoxifen to pregnant Grem1-creERT;R26-LSL-TdTomato dams at E13.5. Consistent with the in situ hybridization findings, Grem1 was expressed within much of the primitive hindlimb mesenchyme within the embryos and gave rise to almost all of the cells within the primitive mesenchyme and the primary spongiosa by E21 (Figures S4E and S4F) .
Taken together, these results confirm that Grem1 expression marked a new, endogenous skeletal stem cell, in development and adulthood, which lacked any significant capacity for adipogenesis. As a result, it does not meet the minimal criteria for MSCs (Dominici et al., 2006) . Thus, we named these Grem1 + stem cells as osteochondroreticular ''OCR stem cells'' in reference to the earlier concept of the osteochondroprogenitor (Ducy et al., 1997 Figure 4B ), Nes-creER T recombined R26-LSL-TdTomato in approximately 4% of all bone marrow Nes-GFP cells by 6-8 weeks ( Figure 4C ). This included metaphyseal ( Figure 4D ), periarteriolar ( Figure 4E ), and perisinusoidal Nes-GFP cells (Figures 4F-4H ). In keeping with previous perisinusoidal lineage-tracing studies, this Nes-creER T line did not generate cartilage or trabecular bone by 6-8 weeks (Ding et al., 2012; Mizoguchi et al., 2014 Next, we tested whether Grem1 + cells could be transplanted into the fracture site. We harvested and expanded a clonal population of Grem1 + OCR stem cells. This clone, mixed with hydrogel, was applied to the fracture site at the time of injury and engrafted into the callus of the recipient wild-type mice ( Figures 5I and 5J) . The transplanted cells differentiated into osteoblasts (alkaline phosphatase-expressing) within the fracture callus ( Figure 5K) . OCR stem cells self-renewed within the callus and were recovered from the recipient animals and rapidly expanded again in fracture callus cultures ( Figure 5L ). The Grem1 + OCR stem cells cultured from the fracture callus and expanded in vitro could be serially transplanted into a second fracture ( Figure S5E ). Thus, Grem1 expression identifies developmental and adult, both physiological and reactive, endogenous OCR stem cells amenable to serial transplantation.
Grem1 Expression also Defines a New iRSC
Could Grem1 also mark extramedullary connective tissue stem cells? The small intestine was selected as our extramedullary organ of interest because the gut is known to contain multipotent mesenchymal stromal cells (Powell et al., 2011) . It is worth emphasizing that we searched for a connective tissue stem cell within the lamina propria and not for an epithelial stem cell, such as that previously identified by Lgr5 expression (Barker et al., 2007) . Furthermore, the small intestine does not contain (I) A Grem1 + clone, after adult induction, was expanded in vitro. An osteotomy with internal fixation was performed in wild-type mice, at which point 500 3 10 6 clonal cells (red) were irrigated into the surgical field. Seven days later, the Grem1 clone had engrafted (J), the site of injury was identified by TdTomato fluorescence imaging, and recombined cells (fluorescent red) differentiated into osteoblastic cells (K) (alkaline phosphatase positive cells, red-brown, white arrows) in the callus (sequential fluorescence microscopy and ALP staining performed on the same slide).
(L) Callus culture was performed, and the recombined Grem1 cells were easily recovered in vitro and serially transplanted into a secondary fracture ( Figure S5E ).
bone and cartilage, and thus we were not expecting to find a bona fide OCR stem cell. Rather, we were interested in testing for an organ-relevant connective tissue stem cell, sharing Grem1 expression and the defining stem cell characteristics of self-renewal and multipotentiality. The connective tissue immediately beneath the intestinal epithelium is a mesenchymal sheath that invests the entire intestinal gland (Powell et al., 2011) . Adult Grem1 recombination (24 hr after 6 mg of tamoxifen by oral gavage, Grem1-creER T ;R26-mT/mG) identified single cells (Grem1 + = green) immediately beneath the epithelium at the junction between the small-intestinal crypt and villus, a region known as the intestinal isthmus ( Figures 6A and 6B) . In situ hybridization confirmed Grem1 expression within periepithelial isthmus cells, and these cells were also positive in the Grem1-LacZ knockin line (Data S2A-S2F) (Khokha et al., 2003) . Single periepithelial Grem1 cells divided slowly (BrdU incorporation over 1 month of continuous dosing; Data S2G). Over time, the fluorescently tagged Grem1 + cells gave rise to reticular, periepithelial mesenchymal lineages throughout both the crypt and villus sheaths ( Figures 6B-6E ). The Grem1 + cells differentiated into both Acta2-positive myofibroblasts ( Figure 6F ) and Acta2-negative, but Ng2-positive, stromal cells (Data S2H). Grem1 cells gave rise to an intricate reticular network of cells that invested the entire gland ( Figures 6B-6E , Movie S1). The Grem1 lineage was distinct from the closely associated s100b (Data S2I) and Nes-GFP positive periepithelial glial sheath (Data S2J) (Belkind-Gerson et al., 2013) . The Grem1 + cell lineage was intimately related to the overlying intestinal epithelium (Figures 6G and Data S2K) . After 6 to 9 months, intestinal Grem1 cells had expanded to give rise to the mesenchymal sheath subjacent to the Lgr5 + crypt base columnar stem cell zone ( Figures 6B, 6C , and 6E) (Barker et al., 2007) . After 12 months, the cells had also renewed the periepithelial mesenchymal sheath to the tip of the villi ( Figure 6B ). The Grem1 + cells at the isthmus selfrenewed so that their fluorescently tagged lineage persisted across the entire crypt-villus axis for at least 2 years after adult tamoxifen induction (Data S2L). Perinatal induction at P1 led to accelerated intestinal mesenchymal tracing (at 6 weeks), providing further proof of the clonality of the Grem1 lineage within the mesenchymal sheath (Grem1-creER T ;R26-Confetti mice; Data S2M). The Grem1 lineage also identified small-intestinal CFU-Fs (Data S2N). Similar patterns of lineage tracing were evident throughout the entire gastrointestinal tract, including the stomach (Data S2O). Grem1 also identified a progenitor population within the skin (Data S2O). The exact nature of these cells, however, requires further study.
Extending the concept of connective tissue stem cells to extramedullary mesenchyme, however, requires that the model be rigorously validated in vivo. We adapted a protocol for generating tissue-engineered small intestines (TESIs) to test whether Grem1 + intestinal mesenchymal cells could be transplanted to generate the small-intestinal, periepithelial mesenchymal sheath within the recipient's TESI graft (Levin et al., 2013) . Grem1-creER T ;R26-LSL-TdTomato donor small-intestinal organoid units were transplanted into the omentum of recipient wildtype mice. Only one or two Grem1 + cells were present within the harvested donor units ( Figure 6H ), but they were able to expand and restore the intestinal mesenchymal sheath in the TESI ( Figures 6I and Data S2P) . Thus, small-intestinal Grem1 + cells self-renew and clonally generate multiple distinct, compartment-relevant mesenchymal lineages and can be transplanted to recapitulate the periepithelial mesenchymal sheath, confirming that they are connective tissue stem cells. In this context, we refer to them as iRSCs. We use this term, iRSCs, to reflect their morphology and the reticular network formed by these cells and in reference to their Grem1-expressing reticular counterparts in the bone marrow.
DISCUSSION
Despite intensive investigation, the identity of an endogenous ''skeletal stem cell'' has remained elusive. We generated an inducible Cre line, driven by the enhancer elements of the BMP antagonist Grem1, to identify and lineage trace rare skeletal stem cells in vivo. Adult Grem1 OCR stem cells were found beside the growth plate and the trabecular bone, where they generated and maintained articular and growth plate cartilage, bone and reticular marrow stromal cells, but not fat. Adult Grem1 OCR stem cells did not overlap with perisinusoidal Nes-GFP MSCs, appear to be more clonogenic in vitro than Nes-GFP MSCs, and make a far greater contribution to early postnatal skeletogenesis than traditional perisinusoidal MSCs (Ding et al., 2012; Zhou et al., 2014) . This study complements the existing, perisinusoidal MSC model of postnatal skeletogenesis ( Figure 7 ) (Bianco et al., 2013) . We have also identified Grem1-expressing, reticular stem cells in the small intestine, the iRSCs, that self-renew to maintain the multilineage periepithelial, mesenchymal sheath. The iRSCs are distinct from, but analogous to, their Grem1-expressing OCR stem cells in the bone. Each has an organ-appropriate mesenchymal repertoire, but these Grem1-expressing stem cells are united by their capacity for self-renewal, multipotentiality, and continued functionality following transplantation. Bone and cartilage could develop from a population of dedicated and committed postnatal progenitors (as with pancreatic beta cells). Alternatively, they could arise from a multipotent stem cell capable of generating bone, cartilage, and accessory elements, such as adipocytes and pericytes. A third model, which we favor, suggests that discrete stem cells make temporal and lineage-specific contributions to skeletal development and maintenance (Takashima et al., 2007) . That is, the OCR stem cell is a substantial skeletal stem cell in development and early postnatal life, but over time, the perisinusoidal MSC increases its contribution to skeletal homeostasis, such that ultimately adult mesenchymal tissues are maintained from two separate, but complementary, stem cell pools (Figure 7) .
Perisinusoidal Nes-GFP MSCs fulfill the in vitro criteria of MSCs (Mé ndez-Ferrer et al., 2010); however, they make little endogenous contribution to skeletogenesis, at least during early life (Figure 4) (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014) . In contrast, OCR stem cells are most active during development, giving rise to trabecular bone, cartilage, and reticular marrow stromal cells. Although it was reported that all adult bone marrow CFU-Fs are Nes-GFP + (Mé ndez-Ferrer et al., 2010), Grem1 OCR stem cells are negative for Nes-GFP and yet are clonogenic (Figures 1D-1G ). We believe that this discrepancy may arise from differences in our isolation and culture of the bone marrow. Bone marrow Nes-GFP cells were originally isolated by bone flush without reported collagenase digestion (Mé ndez-Ferrer et al., 2010) , which enhances the yield of CFU-Fs (Morikawa et al., 2009 (Park et al., 2012) , whereas in the original Nes-GFP MSC study, CD45 -alone was used as the mesenchymal arbiter (Mé ndez-Ferrer et al., 2010) . This may have resulted in some CD31 + endothelial cells being collected, and given that Nes-GFP is expressed in bone marrow endothelium (Zhou et al., 2014) , did not lead to significant genetic recombination of trabecular bone or cartilage in early life. In contrast, trabecular bone and cartilage are clearly derived from immediately beneath the intestinal stem cells at the crypt base (B and C). Axes are provided to indicate the longitudinal and circumferential axes (x and y), and ''CVA'' to designate the crypt-villus, or radial, axis. (D) The mesenchymal expansion was plotted relative to the adjacent epithelial position; 20 well-orientated crypt-villus columns were quantified per mouse. n = 3-5 mice at each time point; Kruskal-Wallis analysis (p < 0.0001) and post-hoc pairwise Mann-Whitney tests, corrected for multiple comparisons, revealed significant differences (****p % 0.0001, *p % 0.05). 
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+ cells. Thus, based on our data, and those of others (Ding et al., 2012; Mizoguchi et al., 2014; Zhou et al., 2014) , we conclude that there are at least two skeletogenic stem cells contributing to postnatal bone (Figure 7) . Remarkably, only OCR stem cells appear to generate articular and growth-plate cartilage during development, and the contribution of perisinusoidal MSCs is modest until later adulthood, at which point the perisinusoidal MSCs are ultimately capable of generating fat, bone, and cartilage, particularly following injury (Figure 7 ) (Zhou et al., 2014) . We propose that the OCR stem cell is vital in skeletogenesis, whereas the traditional perisinusoidal MSCs gradually increase their skeletal contribution over time. Traditional MSCs appear to partner with OCR stem cells to repair bone in the event of fracture, but this may again depend on the developmental stage at which the injury occurs (Figure 7) .
In contrast to perisinusoidal MSCs, the Grem1 OCR stem cells did not generate adipocytes in vivo or in vitro. Thus, although the Grem1 + cell is multipotent (giving rise to osteoblasts, chondrocytes, and reticular marrow stromal cells) and a bone fide stem cell, it is not the usual origin of adipocytes, at least under the conditions examined. The relative ascendency of perisinusoidal MSCs in later adulthood could potentially explain the increasing adipogenesis evident in the bone marrow in later life.
Our selected marker, Grem1, is a BMP antagonist that is especially important for skeletal patterning and contributes to postnatal skeletal homeostasis (Bé nazet et al., 2009; Canalis et al., 2012; Khokha et al., 2003) . BMP signaling in skeletogenesis expands primitive mesenchymal cells, laying the foundation for subsequent endochondral ossification (Kronenberg, 2003) . Despite expression of the BMP antagonist Grem1, BMP signaling was elevated in OCR stem cells compared to the Grem1-negative mesenchymal cells. Increased BMP signaling is consistent with the location of OCR stem cells, which is immediately adjacent to the BMP-producing growth plate, and our microarray and qPCR data suggest that OCR stem cells also produce Bmps that may act in an autocrine fashion (Kronenberg, 2003) .
Researchers have harvested MSC-like cells from many different adult organs (Crisan et al., 2008) . In the small intestine, single Grem1 + iRSCs immediately subjacent to the epithelium at the junction between the small-intestinal crypt and villus (the intestinal isthmus) undergo slow division, to ultimately generate the entire periepithelial sheath of the crypt and villus, forming a closely connected mesenchymal network. In adulthood, this process takes about one year, during which time the Grem1 iRSCs give rise to both Acta2-positive myofibroblasts and Acta2-negative periepithelial fibroblasts, thus establishing their endogenous self-renewal and compartment-specific multipotentiality.
The Grem1 + iRSC is a different cell from the Grem1 + OCR stem cell, with discrete functions and distinct lineage potential, namely periepithelial mesenchyme rather than bone and cartilage. Nevertheless, it shares with the Grem1 OCR stem cell a stellate morphology, relative quiescence, and most importantly the properties of endogenous self-renewal and mesenchymal multipotentiality.
The stem cell responsible for developing bone and cartilage in vivo, the OCR stem cell, appears to show great promise for skeletal tissue engineering, particularly for conditions such as osteoarthritis, osteoporosis, and fracture. Grem1 OCR stem cells could be harvested from a donor animal, expanded in vitro, and transplanted, both directly and serially, into the femurs of fractured recipient animals, resulting in osteochondral differentiation in the callus. Future studies will be needed to compare the ability of Grem1 + cells to heal skeletal diseases relative to those of other mesenchymal progenitor populations. Our discovery of analogous iRSCs is also likely to be important in intestinal replacement and repair and may inform mesenchymal hierarchy in other complicated connective tissues, including the tumor microenvironment. Taken together, our findings confirm the existence and relevance of bone, cartilage, and reticular stromal stem cells and present a paradigm shift in understanding the diverse origins of connective tissues in health, aging, and disease.
EXPERIMENTAL PROCEDURES Mice
We used the following lines: Nes-GFP (Mignone et al., 2004) , Nes-CreER T2 (Dranovsky et al., 2011) , Grem1-LacZ (Khokha et al., 2003) , Acta2-RFP (Magness et al., 2004) , R26-LSL-ZsGreen (Madisen et al., 2010) , R26-LSLTdTomato (Madisen et al., 2010) , R26-LSL-mT/mG (Muzumdar et al., 2007) , 2.3ColGFP (Kalajzic et al., 2002) , R26-LSL-Confetti (Snippert et al., 2010) , and R26-LSL-DTA (Voehringer et al., 2008) (Table S1B ). The R26-LSLmT/mG was used in the intestine to better appreciate intestinal architecture, but for the bone marrow, either the R26-LSL-ZsGreen or the R26-LSLTdTomato was used to enable the addition of a second reporter, such as Nes-GFP, 2.3colGFP or Acta2-RFP. We generated the Grem1-CreER T transgenic by BAC recombineering (clone RP24-317C19), as previously described (Sharan et al., 2009 ). The recombineering primers amplified the CreER T -pA-fNf cassette with 60 bp homology arms upstream and downstream of the Grem1 translational start site in exon 2 (Table S1A) . We generated three founder lines. Line 3 displayed the greatest recombination following adult tamoxifen induction, and it was backcrossed six generations to C57BL/6J. All experiments were performed according to the guidelines of the Institute of Comparative Medicine at Columbia University.
Marrow Stromal Cell Isolation
Long bones of the arms and legs were harvested and gently disrupted using a mortar and pestle, in PBS with 2% FBS and 1 mM EDTA. The bone and all of the liberated bone marrow were collected and digested in 0.25% collagenase type I (Worthington, Lakewood, NJ, USA, LS004196) in PBS with 20% FBS, for cell culture or flow cytometry.
Clonal In Vitro Bone Marrow MSC Culture, Clonogenicity Assays, and Differentiation Marrow stromal cells were plated at clonal density and cultured for 14 days in aMEM + 10% defined MSC FBS + 1% penicillin/streptomycin. The total number of colonies, defined as R50 cells, were stained with Giemsa. The number of clones were reported as (CFU-Fs)/1,000 cells plated. For differentiation, single recombined clones were isolated using cloning cylinders and then expanded and split for differentiation using Invitrogen StemPro differentiation products into adipocytes, chondrocytes, and osteoblasts. All in vitro differentiation reported in this study is clonal.
Fracture Studies
Adult Grem1-creER T ;R26-LSL-TdTomato;2.3ColGFP mice were induced with tamoxifen with a 1 week washout period before fracture. Unilateral femoral osteotomy was internally fixed by an angiocatheter. Femurs were harvested at 7 days. For the fracture transplantation, a single Grem1-derived clone (after adult in vivo induction) was expanded in vitro and then 500 3 10 6 cells
were mixed with a HyStem-C(TM) Hydrogel Kit (Glycosan) and injected around the fracture sites of the recipient wild-type mice. The fractured bones were harvested at 7 days. Some of the fracture callus was recultured to recover the donor Grem1 + cells. The fractures were imaged by X-ray and a Kodak
In Vivo Multispectral Imaging System FX (carestream Health) specific for TdTomato fluorescence.
Tissue-Engineered Small Intestines
Organoid units were harvested from 3-week-old, P1 tamoxifen-induced Grem1-creERT;R26-LSL-TdTomato donor mice and transplanted into 8 wild-type adult C57BL/6 mice. The procedure was otherwise performed as previously described (Levin et al., 2013) with the TESIs harvested at 4 weeks post-implantation for analysis. 
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